Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial.
Saved in:
| Title: | Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial. |
|---|---|
| Authors: | Holle, Sarah Louise Duus1 (AUTHOR), Kunkel, Joakim Bo1 (AUTHOR), Hassager, Christian1,2 (AUTHOR), Pecini, Redi1 (AUTHOR), Wiberg, Sebastian1,2,3 (AUTHOR), Palm, Pernille1 (AUTHOR), Holmvang, Lene1 (AUTHOR), Bang, Lia Evi1 (AUTHOR), Kjærgaard, Jesper1 (AUTHOR), Thomsen, Jakob Hartvig4 (AUTHOR), Engstrøm, Thomas1,3 (AUTHOR), Møller, Jacob Eifer1,5 (AUTHOR), Lønborg, Jacob Thomsen1 (AUTHOR), Søholm, Helle1,6 (AUTHOR) helle.soeholm@regionh.dk, Frydland, Martin1 (AUTHOR) |
| Source: | Trials. 10/30/2024, Vol. 25 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17456215 |
|---|---|
| DOI: | 10.1186/s13063-024-08567-y |
